₹ 1,152.45
0.65 (0.06%)Open
1156.7High
1175.6Low
1148.05Prev Close
1151.8P/E
-Median P/E
-P/B
-Median P/B
-Market Cap
675.26BPEG
-Div.Yield
-Bid
-Ask
-Large Cap
675.26B Mkt. Cap.Volatility
-Beta
Genie Says
Influencer Count
-Days | BSE | NSE |
---|
5 | 1,102.70 | 1,102.73 |
10 | 1,103.69 | 1,103.91 |
20 | 1,099.39 | 1,099.55 |
50 | 1,059.07 | 1,059.20 |
100 | 1,067.84 | 1,067.93 |
300 | 967.00 | 967.13 |
BSE
524804NSE
AUROPHARMAISIN
INE406A01037Aurobindo Pharma Limited is an India-based pharmaceutical company. The Company is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, branded pharmaceuticals, generic pharmaceuticals and related services. Its product portfolio is spread over seven therapeutic/product areas encompassing Central nervous systems (CNS), Antiretrovirals (ARVs), Cardiovascular (CVS), SSP - Orals & Sterile, Anti-infectives, Anti-diabetics and Cephalosporins - Orals. It is engaged in developing a range of oncology and hormonal products. It is developing topical as well as transdermal products in the dermatology therapeutic segment. It is also developing about three depot injections based on the microsphere and nano-suspension technology platforms. The Company is marketing its products globally in approximately 150 countries. The Company's subsidiaries include APL Healthcare Limited, Auronext Pharma Private Limited, Auro Peptides Limited, APL Pharma Thai Limited, and others.
K. Nityananda Reddy
Executive Vice Chairman of the Board, Managing Director, PromoterSanthanam Subramanian
Chief Financial OfficerB. Adi Reddy
Compliance Officer, Company SecretaryM. Madan Reddy
Whole-Time DirectorN. Ravikiran
Chief Business Officer